ame:Bloomgren;given-names:G", "name_2": "surname:Cadavid;given-names:D", "name_3": "surname:Dong-Si;given-names:T", "name_4": "surname:Richman;given-names:S", "name_5": "surname:Ticho;given-names:B", "section_type": "REF", "source": "Poster 99 presented at 28th ECTRIMS congress", "type": "ref", "year": "2012"}, "text": "Imaging findings for PML in natalizumab-treated MS patients", "sentences": [], "annotations": [], "relations": []}, {"offset": 31059, "infons": {"fpage": "507", "lpage": "508", "name_0": "surname:Blair;given-names:NF", "name_1": "surname:Brew;given-names:BJ", "name_2": "surname:Halpern;given-names:JP", "pub-id_pmid": "22302545", "section_type": "REF", "source": "Neurology", "type": "ref", "volume": "78", "year": "2012"}, "text": "Natalizumab-associated PML identified in the presymptomatic phase using MRI surveillance", "sentences": [], "annotations": [], "relations": []}, {"offset": 31148, "infons": {"fpage": "1732", "lpage": "1733", "name_0": "surname:Ayzenberg;given-names:I", "name_1": "surname:Lukas;given-names:C", "name_2": "surname:Trampe;given-names:N", "name_3": "surname:Gold;given-names:R", "name_4": "surname:Hellwig;given-names:K", "pub-id_pmid": "22289971", "section_type": "REF", "source": "J Neurol", "type": "ref", "volume": "259", "year": "2012"}, "text": "Value of MRI as a surrogate marker for PML in natalizumab long-term therapy", "sentences": [], "annotations": [], "relations": []}], "annotations": [], "relations": []}]}]